BI
CEROW

Bulldog Investors’s CERo Therapeutics Warrants CEROW Stock Holding History

Bulldog Investors’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48,223
Closed -$3.45K – 183
2023
Q3 		$3.45K Hold
48,223
– – ﹤0.01% 164
2023
Q2 		$2.94K Sell
48,223
-1,059
-2% -$46 ﹤0.01% 182
2023
Q1 		$1.48K Hold
49,282
– – ﹤0.01% 248
2022
Q4 		$2.12K Sell
49,282
-857
-2% -$45 ﹤0.01% 236
2022
Q3 		$4K Sell
50,139
-1,618
-3% -$136 ﹤0.01% 267
2022
Q2 		$5K Sell
51,757
-2,988
-5% -$482 ﹤0.01% 293
2022
Q1 		$11K Buy
+54,745
New +$20.3K ﹤0.01% 297

Other funds holding CEROW

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Bulldog Investors's CEROW Position: Q4 2023 in Review

Bulldog Investors sold out of CERo Therapeutics Warrants (CEROW) in Q4 2023, closing a stake of 48,223 shares — an estimated $3.45K sold.

Bulldog Investors first reported a position in CEROW in Q1 2022 and held it in 7 quarters. The position peaked at $11K in Q1 2022. 40 funds tracked by Wall St. Rank hold CEROW as of Q4 2023.

  • Bulldog Investors reported no remaining CERo Therapeutics Warrants position as of Q4 2023 after selling out during the quarter.
  • Bulldog Investors sold 48,223 CERo Therapeutics Warrants shares in Q4 2023, an estimated $3.45K.
  • Bulldog Investors first reported a position in CERo Therapeutics Warrants in Q1 2022 and held it in 7 quarters.
  • Bulldog Investors's CERo Therapeutics Warrants position peaked at $11K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2023.

Based on Bulldog Investors's 13F filing for Q4 2023, filed 14 Feb 2024.